Американское общество гирудотерапии

Anaphylactoid reactions associated with contaminated heparin from China

Review published in Annales pharmaceutiques francaises (2011)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewКлинические исследованияБезопасность и инфекционный контрольMontpas N et al. · Annales pharmaceutiques francaises, 2011

Abstract

In January 2008, fatal anaphylactoid reaction (AR) was found to be associated with oversulfated chondroitin sulphate (OSCS) contaminated heparin. Although attributed to bradykinin released during contact system activation by OSCS, no final evidence until now exists for a bradykinin release during incubation of contaminated heparin with human plasma. The first objective of our study was to measure and to characterize the kinetic profile of bradykinin release in human plasma incubated with OSCS and contaminated heparin. As these AR occurred mainly in the first minutes of the dialysis session, we examine the different factors likely to influence the kinin-forming capacity of OSCS: dilution of plasma, presence of an angiotensin converting enzyme inhibitor, capacity of the patient to metabolise kinins.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal ArticleReview
Indexed MeSH termsAminopeptidasesAnaphylaxisAngiotensin-Converting Enzyme InhibitorsAnticoagulantsBradykininChinaChondroitin SulfatesDialysisDrug ContaminationHeparinHumansKinins

Резюме

In January 2008, fatal anaphylactoid reaction (AR) was found to be associated with oversulfated chondroitin sulphate (OSCS) contaminated heparin.

Почему это важно для гирудотерапии

This article examines the 2008 crisis of fatal anaphylactoid reactions associated with oversulfated chondroitin sulfate (OSCS)-contaminated heparin, focusing on characterizing the kinetic profile of bradykinin release in human plasma incubated with OSCS and contaminated heparin. It also explores factors likely to influence the kinin-forming capacity of OSCS, such as plasma dilution, angiotensin-converting enzyme inhibitors, and patient kinin metabolism. The study provides mechanistic insight into how contaminants in biological anticoagulant products can trigger severe adverse reactions. However, this work has no direct involvement with leeches or the leech secretome; its relevance to hirudotherapy is purely conceptual and indirect, limited to general safety considerations around biological therapeutics.

Цитирование

Anaphylactoid reactions associated with contaminated heparin from China

Montpas N et al. · Annales pharmaceutiques francaises, 2011

Связанный клинический контекст

Узнайте, как это исследование связано с клинической практикой

Добавлено в библиотеку ASH: May 27, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.